for
Accelerated treatment of
Soft tissue infections and
Intractable wounds
Over 80% of infections resolved*
in patients with intractable wounds
and/or cellulitis.
Over 70% of open wounds healed
or were healing at last follow-up.
Only 30% of chronic wounds
heal after
3 months of standard therapy.
U.S. Wound Registry
Chronic wounds and soft tissue infections
affect over 10 million Medicare patients
Skin and soft tissue infections (SSTIs) develop when bacteria enter through a break in the skin barrier such as from a cut, scrape or needle stick.
The majority heal without complication, but some infections don’t heal.
Those that persist after 1 – 3 months are classified as chronic.
These infections may occur anywhere on the body but the majority are on
the lower extremities or legs.
Pain
Bad odor
Multiple debridements
Multiple courses of antibiotics
Multiple clinic visits
Hospitalizations
Antibiotics given orally or intravenously diffuse throughout the body, resulting in diluted levels at the site of infection.
Biofilm is a protective scaffold
secreted by bacteria
to resist antibiotics
and white blood cells.
Less than 30 minute treatment
High antibiotic level
Biofilm disrupted
Bacteria destroyed
Over 90 patients treated
No adverse events
Over 80% infections resolved
Including MRSA*
*MRSA or methicillin resistant
Staph. aureus
also known as a flesh-eating bacteria
Patient suffered for years
with a nonhealing wound.
Wound healed after
a single Sonofii treatment,
followed by a skin graft.
Sonofii is committed to advance the treatment of soft tissue infections and wounds through innovative technology that accelerates healing to improve the quality of life of patients while lowering the cost of health care.
We are professionals with decades of experience both in patient care and in life science start-ups from inception through commercialization.
If you would like to learn more please contact us: